Genomenon, Inc. funding
Genomenon, Inc., a biotechnology company based in Ann Arbor, MI, filed a Form D with the SEC on July 30, 2026 and reported $6M raised of a $10M offering.
Amount raised$6M
Offering size$10M
Filed with the SECJuly 30, 2026
First saleJuly 15, 2026
IndustryBiotechnology
SecuritiesEquity
LocationAnn Arbor, MI
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far30
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Jul 30